| 发明名称 |
Pharmaceutical composition for the treatment of hepatocellular carcinoma |
| 摘要 |
The invention mainly discloses a pharmaceutical composition for use in the treatment of hepatocellular carcinoma, which comprises thalidomide and a pharmaceutically acceptable carrier.
|
| 申请公布号 |
US2001018445(A1) |
申请公布日期 |
2001.08.30 |
| 申请号 |
US20010768442 |
申请日期 |
2001.01.24 |
| 申请人 |
TTY BIOPHARM COMPANY LIMITED |
发明人 |
HUANG CHUN-YING;WHANG-PENG JIA-KANG;CHEN LI-TZONG;LIU TSANG-WU;CHANG JANG-YANG;HSU MING-CHU |
| 分类号 |
C07D401/04;A61K31/4427;A61K31/445;A61K31/454;A61K45/06;A61K48/00;A61P1/16;A61P35/00;A61P35/04;A61P43/00;(IPC1-7):A61K31/454 |
主分类号 |
C07D401/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
